Bakuchicin alleviates ovalbumin-induced allergic asthma by regulating M2 macrophage polarization. 2024

Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup, Republic of Korea.

OBJECTIVE Asthma is an airway inflammatory disease caused by activation of numerous immune cells including macrophages. Bakuchicin (BKC) is known to exhibit anti-inflammatory effects and type 2 T helper (Th2) regulation, but has not been investigated for airway inflammation. This study aimed to evaluate the effects of BKC on airway inflammation and demonstrate the mechanisms of macrophage polarization. METHODS The anti-inflammatory effects were determined using lipopolysaccharide (LPS)-stimulated macrophages. The ovalbumin (OVA)-induced asthma mouse model was used to evaluate the effects of BKC on airway inflammation and Th2 responses. Moreover, the effect of BKC on macrophage polarization was confirmed in bone marrow-derived macrophages (BMDMs) differentiation. RESULTS BKC suppressed nitric oxide production and expression of pro-inflammatory cytokines by inhibiting signaling pathway in LPS-stimulated macrophages. In an OVA-induced asthma model, BKC treatment alleviated histological changes and mast cell infiltration and reduced the levels of eosinophil peroxidase, β-hexosaminidase, and immunoglobulin levels. In addition, BKC alleviated Th2 responses and M2 macrophage populations in bronchoalveolar fluid. In BMDMs, BKC suppressed IL-4-induced M2 macrophage polarization and the expression of M2 markers such as arginase-1 and Fizz-1 through inhibiting sirtuin 2 levels. CONCLUSIONS BKC could be a drug candidate for the treatment of allergic asthma.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
January 2023, Allergologia et immunopathologia,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
November 2023, International immunopharmacology,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
February 2024, Inflammation,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
April 2024, BMC pharmacology & toxicology,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
January 2021, Frontiers in cell and developmental biology,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
July 2023, Journal of ethnopharmacology,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
January 2021, PloS one,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
January 2018, Translational research : the journal of laboratory and clinical medicine,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
May 2020, Journal of food biochemistry,
Yeon-Yong Kim, and Seungwon Jeong, and Seung Woong Lee, and Seung-Jae Lee, and Mun-Chual Rho, and Sang-Hyun Kim, and Soyoung Lee
September 2023, Experimental cell research,
Copied contents to your clipboard!